Evidence map›Paper›PMID 22682003›Full record

ReviewThe FEBS journal2013

Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Alma N Mohebiany, Roman M Nikolaienko, Samuel Bouyain, Sheila Harroch

Open access · bronzeAbstract readReview
In one paragraph

Review in The FEBS journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Enhancer Reprogramming Reveals the Tumorigenic Role of PTPRZ1 in Lung Squamous Cell Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Crystal structure of the catalytic domain of human RPTPH.Acta crystallographica. Section F, Structural biology communications · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Alma N MohebianyDepartment of Neuroscience, Institut Pasteur de Paris, Paris, France.
Roman M Nikolaienko
Samuel Bouyain
Sheila Harroch
Zero to Three · USInstitut Pasteur · FRUniversity of Missouri–Kansas City · US

Funding

STRUCTURAL AND BIOCHEMICAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE FUNCTIONR01GM088806 · NIGMS · UNIVERSITY OF MISSOURI KANSAS CITY · PI BOUYAIN, SAMUEL · 2010 to 2014
$1.2M
NIGMS NIH HHS R01 GM088806NIGMS NIH HHS R01GM088806
6 · The paper itself

Abstract

Reversible protein phosphorylation plays a pivotal role in intercellular communication. Together with protein tyrosine kinases, protein tyrosine phosphatases (PTPs) are involved in the regulation of key cellular processes by controlling the phosphorylation levels of diverse effectors. Among PTPs, receptor-like protein tyrosine phosphatases (RPTPs) are involved in important developmental processes, particularly in the formation of the nervous system. Until recently, few ligands had been identified for RPTPs, making it difficult to grasp the effects these receptors have on cellular processes, as well as the mechanisms through which their functions are mediated. However, several potential RPTP ligands have now been identified to provide us with unparalleled insights into RPTP function. In this review, we focus on the nature and biological outcomes of these extracellular interactions between RPTPs and their associated ligands.

Indexed as

Protein Structure, TertiaryAnimalsContactin 1HumansIsoenzymesLigandsModels, MolecularProtein BindingReceptor-Like Protein Tyrosine PhosphatasesReceptor-Like Protein Tyrosine Phosphatases, Class 5CNTN1 protein, humanContactin 1IsoenzymesLigandsPTPRZ1 protein, humanReceptor-Like Protein Tyrosine PhosphatasesReceptor-Like Protein Tyrosine Phosphatases, Class 5

Identifiers

PMID22682003
PMCPMC3753797
OpenAlexW1943381782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.